ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →

Thursday, 12 November 2026 Every NSE & BSE announcement, by company

ALFA Filings Every announcement, straight from the exchange

Genomic Valley Biotech Ltd

NSE: GVBL · BSE: 539206 · Pharmaceuticals & Biotechnology · 14 announcements

Share price: ₹52.63
Market cap: ₹16.08 Cr
Revenue (annual): ₹0.27 Cr
Net profit (annual): ₹0.03 Cr
P/E (TTM): -5821.9×Sector 43.8×
Promoter holding: 46.06%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Open Offer 3 Other Announcement 1 Merger & Restructuring 1 Financial Results 1 Board Meeting Date 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

30 Oct 2026 17:59 IST BSE

Financial Results

Genomic Valley Biotech Q2 FY27 Results: Net Loss of ₹0.02 Cr

Genomic Valley Biotech Ltd reported a net loss of ₹0.02 Cr for Q2 FY27.

Key figure: Net loss ₹0.02 Cr

Open full results → Read the filing ↗

Genomic Valley Biotech Ltd by type